Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New stem cell therapy improves stroke outcome in preclinical models

Feb. 9, 2012

Detailed results presented of phase III regorafenib study

Feb. 9, 2012

Carbon nanomaterials display antioxidant characteristics

Feb. 9, 2012

Japanese study compares drugs to retard symptom progression after stroke

Feb. 9, 2012

Bradykinin B1 receptor antagonist reduces pain in vivo

Feb. 8, 2012

New phase I safety data presented on stroke therapy

Feb. 8, 2012

Foretinib shows promise in large papillary renal cell carcinoma study

Feb. 8, 2012

RNA-loaded dendritic cell vaccine shows promise combined with sunitinib

Feb. 8, 2012

Study compares apixaban to warfarin in subgroup of ARISTOTLE participants

Feb. 7, 2012

Temsirolimus shows limited activity in refractory metastatic urothelial cancer

Feb. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...